These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14747615)

  • 41. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
    He J; Yang Y; Yu Y; Li X; Li XM
    Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prefrontal dopamine efflux during exposure to drug-associated contextual cues in rats with prior repeated methamphetamine.
    Lin SK; Pan WH; Yeh PH
    Brain Res Bull; 2007 Jan; 71(4):365-71. PubMed ID: 17208653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
    Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
    Rau KS; Birdsall E; Volz TJ; Riordan JA; Baucum AJ; Adair BP; Bitter R; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):676-82. PubMed ID: 16687477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Peters LE; Harned ME; Seroogy KB
    Ann N Y Acad Sci; 2006 Aug; 1074():272-81. PubMed ID: 17105923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
    Lee NR; Zheng G; Leggas M; Janganati V; Nickell JR; Crooks PA; Bardo MT; Dwoskin LP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):526-543. PubMed ID: 31413138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
    Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
    Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors.
    Czoty PW; Ramanathan CR; Mutschler NH; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2004 Nov; 311(2):720-7. PubMed ID: 15240827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
    Koike K; Hashimoto K; Fukami G; Okamura N; Zhang L; Ohgake S; Koizumi H; Matsuzawa D; Kawamura N; Shimizu E; Iyo M
    Neuropharmacology; 2005 Mar; 48(3):391-7. PubMed ID: 15721171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regional effects of methamphetamine on dopamine transport.
    Chu PW; Seferian KS; Birdsall E; Truong JG; Riordan JA; Metcalf CS; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2008 Aug; 590(1-3):105-10. PubMed ID: 18599036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.
    Raybon JJ; Boje KM
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1252-60. PubMed ID: 17138862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications.
    Hanson GR; Sandoval V; Riddle E; Fleckenstein AE
    Ann N Y Acad Sci; 2004 Oct; 1025():146-50. PubMed ID: 15542712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotoxic regimens of methamphetamine induce persistent expression of phospho-c-Jun in somatosensory cortex and substantia nigra.
    O'Dell SJ; Marshall JF
    Synapse; 2005 Mar; 55(3):137-47. PubMed ID: 15549691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reverse-tolerance phenomenon in methamphetamine-induced behavioral stereotypy and impairment of cliff avoidance reaction after subchronic methamphetamine administration in rats].
    Yoshida S; Numachi Y; Matsuoka H; Fuse Y; Sato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Oct; 15(5):397-403. PubMed ID: 8564732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.
    McFadden LM; Hoonakker AJ; Vieira-Brock PL; Stout KA; Sawada NM; Ellis JD; Allen SC; Walters ET; Nielsen SM; Gibb JW; Alburges ME; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2011 Aug; 65(8):771-7. PubMed ID: 21190217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.
    Baladi MG; Newman AH; Nielsen SM; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2014 Jun; 732():105-10. PubMed ID: 24685638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
    Lee NR; Zheng G; Crooks PA; Bardo MT; Dwoskin LP
    AAPS J; 2018 Feb; 20(2):29. PubMed ID: 29427069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on experimental models of methamphetamine-induced mental disorders--relationship between rat brain dopamine and changes in behavior].
    Koyama T; Ichikawa J; Nakayama M; Inoue T; Matsubara R
    Seishin Shinkeigaku Zasshi; 1988; 90(10):853-62. PubMed ID: 3251269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.